In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
The in vitro and in vivo activities of three newly developed quinolone antimicrobial agents (sparfloxacin, tosufloxacin, and OPC-17116) were investigated. All three agents showed potent in vitro activities against Chlamydia psittaci, C. trachomatis, and C. pneumoniae with MICs that ranged from 0.031...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1993
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187766/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8494377/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.4.801 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|